Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC lessened its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 27.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 628,324 shares of the company’s stock after selling 236,678 shares during the period. Janus Henderson Group PLC’s holdings in Bath & Body Works were worth $31,428,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in BBWI. Norges Bank acquired a new position in shares of Bath & Body Works in the fourth quarter worth $101,669,000. Lone Pine Capital LLC boosted its position in Bath & Body Works by 20.0% during the fourth quarter. Lone Pine Capital LLC now owns 10,448,872 shares of the company’s stock worth $450,973,000 after acquiring an additional 1,742,471 shares during the last quarter. Sound Shore Management Inc. CT grew its stake in Bath & Body Works by 379.2% in the 4th quarter. Sound Shore Management Inc. CT now owns 1,903,258 shares of the company’s stock worth $82,145,000 after acquiring an additional 1,506,110 shares during the period. Cadian Capital Management LP purchased a new stake in Bath & Body Works in the 4th quarter worth approximately $58,266,000. Finally, Vanguard Group Inc. raised its holdings in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock valued at $1,370,458,000 after acquiring an additional 1,102,124 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Price Performance

NYSE BBWI traded up $0.33 on Wednesday, hitting $36.94. 555,546 shares of the company were exchanged, compared to its average volume of 2,896,537. The company’s 50 day moving average price is $41.50 and its 200-day moving average price is $44.20. The firm has a market capitalization of $8.25 billion, a P/E ratio of 9.44, a price-to-earnings-growth ratio of 1.16 and a beta of 1.85. Bath & Body Works, Inc. has a twelve month low of $27.30 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Tuesday, June 4th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.33 by $0.05. Bath & Body Works had a net margin of 11.92% and a negative return on equity of 40.00%. The business had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.37 billion. During the same quarter in the prior year, the firm earned $0.33 EPS. The firm’s quarterly revenue was down .9% on a year-over-year basis. As a group, equities analysts expect that Bath & Body Works, Inc. will post 3.29 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, June 21st. Shareholders of record on Friday, June 7th were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $0.80 annualized dividend and a yield of 2.17%. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.62%.

Wall Street Analyst Weigh In

BBWI has been the topic of several recent analyst reports. Telsey Advisory Group reiterated an “outperform” rating and set a $53.00 price objective on shares of Bath & Body Works in a report on Tuesday, June 4th. Wells Fargo & Company dropped their price objective on shares of Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 24th. BMO Capital Markets lifted their price target on shares of Bath & Body Works from $50.00 to $55.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 5th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Bath & Body Works from $53.00 to $57.00 in a report on Monday, June 3rd. Finally, Piper Sandler dropped their price objective on shares of Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating on the stock in a research note on Thursday, July 11th. Eight analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $47.60.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.